Safety Assessment of Non-Electric uses of nuclear energy (SANE) project investigates the potential of non-electric usage of nuclear energy, the safety aspects of reactors designed for non-electric use as well as the safety implications of the end use. As many of the applications are novel, their use needs to be properly communicated to various stakeholders, and for this the project includes work on risk communication. Non-electric uses are identified in EU SMR pre-Partnership as one of the high level R&D needs, and the understanding of the potential applications and their limitations as well as the challenges in integration of nuclear energy to end use were seen as important issues to be studied. Non-electric uses will be an important way to diversify the income streams of nuclear plants, as the electricity production will become more and more competitive. Nuclear has unique advantages in non-electric uses as it can produce lot of energy locally for large local uses. SANE aims to review potential future uses of nuclear energy in order to facilitate their implementation in the near future. This project aims to provide information for both industrial applications retrofitted to operating nuclear power plants, as well as for novel reactors dedicated for non-electric uses. Information needs for appropriate risk communication is studied with case studies in several countries, and a specific study on communications during abnormal situations is done based on the events that transpired in Ukraine during Russia's invasion.

BIORIMA stands for Biomaterial Risk Management. BIORIMA aims to develop an integrated risk management (IRM) framework for nano-biomaterials (NBM) used in Advanced Therapeutic Medicinal Products (ATMP) and Medical Devices (MD). The BIORIMA RM framework is a structure upon which the validated tools and methods for materials, exposure, hazard and risk identification/assessment and management are allocated plus a rationale for selecting and using them to manage and reduce the risk for specific NBM used in ATMP and MD. Specifically, the IRM framework will consist of: (i) Risk Management strategies and systems, based on validated methodologies, tools, and guidance, for monitoring and reducing the risks together with methods for evaluating them; (ii) Validated methodologies and tools to identify the potential Exposure and Hazard posed by NBM to humans and the environment; (iii) A strategy for Intelligent Testing (ITS) and Tiered Risk Assessment for NBM used in ATMP and MD. BIORIMA workplan consists of 7 workpackages covering the major themes: Materials, Exposure, Hazard and Risk. BIORIMA will generate methods and tools for these themes for use in risk evaluation and reduction. The BIORIMA toolbox will consist of validated methods/tools for materials synthesis; reference materials bank; methods for human/environment exposure assessment and monitoring; (eco)-toxicology testing protocols; methods for prevention of accidental risks – massive release or explosion – A tiered risk assessment method for humans/environment; An intelligent testing strategy for NBM and risk reduction measures, including the safer-by-design approach. BIORIMA will deliver a web-based Decision Support System to help users, especially SME, evaluate the risk/benefit profile of their NBM products and help to shorten the time to market for NBM products.